elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57492451-05A93117-4AB9-4B61-85C3-DD1249595F65
Q57492451-05A93117-4AB9-4B61-85C3-DD1249595F65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57492451-05A93117-4AB9-4B61-85C3-DD1249595F65
Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
P2860
Q57492451-05A93117-4AB9-4B61-85C3-DD1249595F65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57492451-05A93117-4AB9-4B61-85C3-DD1249595F65
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
93cd0da9249118622729f5e5f24d91af042c204f
P2860
Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.